Lee S, Zambas ED, Marsh WL, Redman CM. Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci U S A 1991;88:6353–7.10.1073/pnas.88.14.6353Search in Google Scholar
Table of blood group antigens within systems. http://www. isbtweb.org/fileadmin/user_upload/files-2015/red%20cells/ links%20tables%20in%20introduction%20text/Table%20 blood%20group%20antigens%20within%20systems%20 v4.0%20141124.pdf. Accessed 25 June 2015.Search in Google Scholar
Coombs RR, Mourant AE, Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946;1: 264–6.10.1016/S0140-6736(46)91925-3Search in Google Scholar
Levine P, Backer M, Wigod M, Ponder R. A new human hereditary blood property (Cellano) present in 99.8% of all bloods. Science 1949;109:464–6.10.1126/science.109.2836.464Search in Google Scholar
Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol. 2000;37:113-21.10.1016/S0037-1963(00)90036-2Search in Google Scholar
Redman CM, Lee S. A historical perspective on the discovery of the Kell blood group carriers. Transfusion 2013;53: 2831–3.Search in Google Scholar
Camara-Clayette V, Rahuel C, Lopez C, et al. Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells. Biochem J 2001;356: 171–80.10.1042/bj3560171Search in Google Scholar
Rojewski MT, Schrezenmeier H, Flegel WA. Tissue distribution of blood group membrane proteins beyond red cells: evidence from cDNA libraries. Transfus Apher Sci 2006;35:71–82.10.1016/j.transci.2006.05.008Search in Google Scholar
Russo D, Wu X, Redman CM, Lee S. Expression of Kell blood group protein in nonerythroid tissues. Blood 2000;96:340–6.10.1182/blood.V96.1.340Search in Google Scholar
Lee S, Lin M, Mele A, et al. Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 1999; 94:1440–50.10.1182/blood.V94.4.1440Search in Google Scholar
Anstee DJ, Ridgwell K, Tanner MJ, Daniels GL, Parsons SF. Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma. Biochem J 1984;221: 97–104.10.1042/bj2210097Search in Google Scholar
Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994;77:869–80.10.1016/0092-8674(94)90136-8Search in Google Scholar
De Franceschi L, Bosman GJ, Mohandas N. Abnormal red cell features associated with hereditary neurodegenerative disorders: the neuroacanthocytosis syndromes. Curr Opin Hematol 2014;21:201–9.10.1097/MOH.000000000000003524626044Search in Google Scholar
Lee S. The value of DNA analysis for antigens of the Kell and Kx blood group systems. Transfusion 2007;47:32S–39S.10.1111/j.1537-2995.2007.01308.x17593284Search in Google Scholar
Allen FH Jr, Lewis SJ. Kpa (Penney), a new antigen in the Kell blood group system. Vox Sang 1957;2:81–7.Search in Google Scholar
Yazdanbakhsh K, Lee S, Yu Q, Reid ME. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999;94:310–8.10.1182/blood.V94.1.310.413k12_310_318Search in Google Scholar
Kormoczi GF, Scharberg EA, Gassner C. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3. Transfusion 2009;49:733–9.10.1111/j.1537-2995.2008.02031.x19347978Search in Google Scholar
Bosco A, Xenocostas A, Kinney J, Cadwell CM, Zimring JC. An autoanti-Kp b immunoglobulin M that simulates antigen suppression. Transfusion 2009;49:750–6.10.1111/j.1537-2995.2008.02045.x19170996Search in Google Scholar
Seyfried H, Gorska B, Maj S, Sylwestrowicz T, Giles CM, Goldsmith KL. Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia. Vox Sang 1972;23:528–36.10.1111/j.1423-0410.1972.tb03846.x4657687Search in Google Scholar
Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacan-thocytosis: genotype and phenotype. Ann Neurol 2001;50: 755–64.10.1002/ana.1003511761473Search in Google Scholar
Lee S, Zambas E, Green ED, Redman C. Organization of the gene encoding the human Kell blood group protein. Blood 1995;85:1364–70.10.1182/blood.V85.5.1364.bloodjournal8551364Search in Google Scholar
Zelinski T, Coghlan G, Myal Y, et al. Genetic linkage between the Kell blood group system and prolactin-inducible protein loci: provisional assignment of KEL to chromosome 7. Ann Hum Genet 1991;55:137–40.10.1111/j.1469-1809.1991.tb00406.x1683210Search in Google Scholar
Lee S, Debnath AK, Redman CM. Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11. Blood 2003;102:3028–34.10.1182/blood-2003-05-156412842980Search in Google Scholar
Lee S, Wu X, Reid M, Redman C. Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 1995;35:822–5.10.1046/j.1537-2995.1995.351096026362.x7570911Search in Google Scholar
Lee S, Wu X, Reid M, Zelinski T, Redman C. Molecular basis of the Kell (K1) phenotype. Blood 1995;85:912–6.10.1182/blood.V85.4.912.bloodjournal854912Search in Google Scholar
Lee S, Wu X, Son S, et al. Point mutations characterize KEL10, the KEL3, KEL4, and KEL21 alleles, and the KEL17 and KEL11 alleles. Transfusion 1996;36:490–4.10.1046/j.1537-2995.1996.36696269505.x8669078Search in Google Scholar
Yu LC, Twu YC, Chang CY, Lin M. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens. J Biol Chem 2001;276:10247–52.10.1074/jbc.M00987920011134029Search in Google Scholar
Names for Kell (ISBT 006) Blood Group Alleles. http://www. isbtweb.org/fileadmin/user_upload/files-2015/red%20 cells/blood%20group%20allele%20terminology/allele%20 tables/006%20KEL%20Alleles%20v3.0%20131028.pdf. Accessed 25 June 2015.Search in Google Scholar
Lee S, Russo DC, Reid ME, Redman CM. Mutations that diminish expression of Kell surface protein and lead to the Kmod RBC phenotype. Transfusion 2003;43:1121–5.10.1046/j.1537-2995.2003.00472.x12869119Search in Google Scholar
Tormey CA, Stack G. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009;114:4279–82.10.1182/blood-2009-06-22779319713462Search in Google Scholar
Tormey CA, Stack G. The persistence and evanescence of blood group alloantibodies in men. Transfusion 2009;49:505–12.10.1111/j.1537-2995.2008.02014.x19040411Search in Google Scholar
Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008;13: 207–14.10.1016/j.siny.2008.02.00718396474Search in Google Scholar
Chiaroni J, Dettori I, Ferrera V, et al. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol 2006;132:374–8.10.1111/j.1365-2141.2005.05868.x16409303Search in Google Scholar
Westhoff CM, Reid ME. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology 2004;20:37–49.10.21307/immunohematology-2019-420Search in Google Scholar
Bansal I, Jeon HR, Hui SR, et al. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km. Vox Sang 2008;94:216–20.10.1111/j.1423-0410.2007.01021.xSearch in Google Scholar
Russo DC, Oyen R, Powell VI, et al. First example of anti-Kx in a person with the McLeod phenotype and without chronic granulomatous disease. Transfusion 2000;40:1371–5.10.1046/j.1537-2995.2000.40111371.xSearch in Google Scholar
Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247–52.10.1016/0002-9378(94)90477-4Search in Google Scholar
Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79:239–44.10.1016/0020-7292(92)90957-KSearch in Google Scholar
Moise KJ Jr, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 2012;120:1132–9.10.1097/AOG.0b013e31826d7dc1Search in Google Scholar
Bony V, Gane P, Bailly P, Cartron JP. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation. Br J Haematol 1999;107:263–74.10.1046/j.1365-2141.1999.01721.x10583211Search in Google Scholar
Daniels G, Hadley A, Green CA. Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion 2003;43:115–6.10.1046/j.1537-2995.2003.00327.x12519439Search in Google Scholar
Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798–803.10.1056/NEJM1998031933812049504940Search in Google Scholar
Grant SR, Kilby MD, Meer L, Weaver JB, Gabra GS, Whittle MJ. The outcome of pregnancy in Kell alloimmunisation. BJOG 2000;107:481–5.10.1111/j.1471-0528.2000.tb13266.x10759266Search in Google Scholar
Stephen J, Cairns LS, Pickford WJ, Vickers MA, Urbaniak SJ, Barker RN. Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen. Blood 2012;119:5563–74.10.1182/blood-2012-02-41032422490333Search in Google Scholar
